Gaayatri Silvaraju1, Nur Airin Syahira Johari1, Siti Hajar Noor Sharaani1, Rosniza Razali2, Nurul Akmarina Mohd Abdul Kamal1*
1. Faculty of Chemical and Process Engineering Technology, Universiti Malaysia Pahang Al-Sultan Abdullah (UMPSA), Gambang 26300, Pahang, Malaysia
2. Bahagian Teknologi Perubatan, Agensi Nuklear Malaysia, 43000 Kajang, Selangor, Malaysia
*Corresponding author: Nurul Akmarina Mohd Abdul Kamal.
ABSTRACT
INTRODUCTION: This study examines the encapsulation of Gliclazide (GLI) into nano-sized Zeolitic Imidazolate Framework-8 (nZIF-8) as a technique for drug repurposing in targeted anticancer therapy.
OBJECTIVE(S): The objective of this study is to encapsulate GLI into nZIF-8 and evaluate its potential as a targeted nanocarrier for repurposed anticancer drug delivery.
MATERIALS & METHODS: GLI was loaded at doses of 5, 10, and 15 mg/mL using a pot solvothermal method.
RESULTS: UV–Vis Spectrometry analysis demonstrated great encapsulation efficiency (≥98%) at concentrations of 5 and 10 mg/mL, with a decline to below 83% at 15 mg/mL. Dynamic Light Scattering (DLS) demonstrated an increase in particle size with GLI loading, hence validating effective encapsulation and the expansion of nanocarriers. PXRD verified that nZIF-8 preserved its crystalline structure after loading. Current analyses (FTIR, BET, SEM, TGA) aim further to elucidate chemical interactions, porosity, and shape.
CONCLUSION: The findings indicate that nZIF-8 is a stable, pH-responsive nanocarrier with significant promise for regulated drug delivery, especially at 10 mg/mL GLI concentrations. The platform shows potential for enhancing repurposed medication techniques in cancer therapy.
KEYWORDS: Gliclazide, Zeolitic Imidazolate Framework-8 (ZIF-8), Nanocarrier, Targeted Anticancer Drug Delivery, Encapsulation-efficiency


